Robert D. Budens

Array ( [id] => 2856856 [patent_doc_number] => 05084391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-28 [patent_title] => 'Monoclonal antibody to the interleukin-2-receptor and its use' [patent_app_type] => 1 [patent_app_number] => 7/343091 [patent_app_country] => US [patent_app_date] => 1989-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4955 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/084/05084391.pdf [firstpage_image] =>[orig_patent_app_number] => 343091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2715616 [patent_doc_number] => 05053491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-10-01 [patent_title] => 'Monoclonal antibodies and cell lines for parathyroid tissue-specific antigen' [patent_app_type] => 1 [patent_app_number] => 7/342312 [patent_app_country] => US [patent_app_date] => 1989-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5613 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/053/05053491.pdf [firstpage_image] =>[orig_patent_app_number] => 342312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2948759 [patent_doc_number] => 05180813 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => 'Early envelope glycoprotein of human cytomegalovirus (HMCV) and monoclonal antibodies to the glycoproteins' [patent_app_type] => 1 [patent_app_number] => 7/328227 [patent_app_country] => US [patent_app_date] => 1989-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7647 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180813.pdf [firstpage_image] =>[orig_patent_app_number] => 328227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2854535 [patent_doc_number] => 05084269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-28 [patent_title] => 'Adjuvant for dose treatment with antigens' [patent_app_type] => 1 [patent_app_number] => 7/312675 [patent_app_country] => US [patent_app_date] => 1989-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2647 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/084/05084269.pdf [firstpage_image] =>[orig_patent_app_number] => 312675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2822091 [patent_doc_number] => 05173420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-22 [patent_title] => 'Monoclonal antibody recognizing un-natural ganglioside GD3' [patent_app_type] => 1 [patent_app_number] => 7/310654 [patent_app_country] => US [patent_app_date] => 1989-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 8 [patent_no_of_words] => 3070 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/173/05173420.pdf [firstpage_image] =>[orig_patent_app_number] => 310654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2670912 [patent_doc_number] => 05047507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-10 [patent_title] => 'Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen' [patent_app_type] => 1 [patent_app_number] => 7/293467 [patent_app_country] => US [patent_app_date] => 1989-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9317 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/047/05047507.pdf [firstpage_image] =>[orig_patent_app_number] => 293467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4345722 [patent_doc_number] => 06214537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Synthetic peptides and mixtures thereof for detecting HIV antibodies' [patent_app_type] => 1 [patent_app_number] => 7/281205 [patent_app_country] => US [patent_app_date] => 1988-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9620 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214537.pdf [firstpage_image] =>[orig_patent_app_number] => 281205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2783009 [patent_doc_number] => 05141864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-08-25 [patent_title] => 'Monoclonal antibody recognizing alpha 2.fwdarw.3 bonds' [patent_app_type] => 1 [patent_app_number] => 7/270205 [patent_app_country] => US [patent_app_date] => 1988-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4191 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/141/05141864.pdf [firstpage_image] =>[orig_patent_app_number] => 270205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2775640 [patent_doc_number] => 05132405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-21 [patent_title] => 'Biosynthetic antibody binding sites' [patent_app_type] => 1 [patent_app_number] => 7/213671 [patent_app_country] => US [patent_app_date] => 1988-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 10272 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/132/05132405.pdf [firstpage_image] =>[orig_patent_app_number] => 213671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2977217 [patent_doc_number] => 05225540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-06 [patent_title] => 'Monoclonal antibodies to tissue plasminogen activator (T-PA) which prolong its functional half-life' [patent_app_type] => 1 [patent_app_number] => 7/186277 [patent_app_country] => US [patent_app_date] => 1988-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5830 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/225/05225540.pdf [firstpage_image] =>[orig_patent_app_number] => 186277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3093218 [patent_doc_number] => 05298419 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-29 [patent_title] => 'Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 7/176159 [patent_app_country] => US [patent_app_date] => 1988-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6501 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/298/05298419.pdf [firstpage_image] =>[orig_patent_app_number] => 176159 [rel_patent_id] =>[rel_patent_doc_number] =>)